Clinical Trials Directory

Trials / Completed

CompletedNCT00920400

Diagnostic Value of Fecal Calprotectin in Disorders of the Upper Gastrointestinal Tract

Value of Fecal Calprotectin in Upper Gastrointestinal Disease

Status
Completed
Phase
Study type
Observational
Enrollment
287 (actual)
Sponsor
University Hospital, Basel, Switzerland · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Fecal calprotectin is a very sensitive non-invasive inflammation marker in the detection of inflammatory bowel disease and, to a lesser degree, has also proven to be useful in adenomatous polyps, neoplasias, and infectious gastroenteritis. Elevated calprotectin levels can also be found in patients with lesion only in the upper gastrointestinal tract. However, the diagnostic value of calprotectin has never been tested in this setting. The aim of the study is therefore to determine the diagnostic value of fecal calprotectin in patients with diseases of the upper gastrointestinal tract.

Conditions

Timeline

Start date
2008-03-01
Primary completion
2009-09-01
Completion
2009-12-01
First posted
2009-06-15
Last updated
2010-01-12

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT00920400. Inclusion in this directory is not an endorsement.

Diagnostic Value of Fecal Calprotectin in Disorders of the Upper Gastrointestinal Tract (NCT00920400) · Clinical Trials Directory